8 Strong Recommendations for 2015 Including FB, XOM And BABA
TipRanks | Feb 13, 2015 09:46AM ET
By Carly Forster
2014 was an eventful year on Wall Street with many ups and downs. Now that 2015 is here, many investors have been wondering which stocks they should jump on and which stocks they should avoid. But how are investors supposed to know which stocks those are?
Strong Buy .
5-Star analyst Alan Carr of Needham recently reiterated a Buy rating on Gilead Sciences on January 28th, ahead of the company’s fourth quarter 2014 earnings scheduled for Tuesday, February 3rd. He reasoned his Buy rating on increased sales expectations of Sovaldi and Harvoni, noting “Given superior profile relative to other agents… we expect the drug to hold a dominant share of the market. We expect real-world efficacy and safety data to be generally supportive of Harvoni.”
Gilead Sciences is currently valued at $151.1 billion.
Alibaba Group Holdings Ltd (NYSE:BABA):
E-commerce giant Alibaba broke records having the biggest IPO in history on August of 2014. Since then, the company’s stock has increased about 32%. Alibaba has been at the forefront of the rapidly growing Chinese e-commerce market despite facing accusations of not taking action against the sale of fake goods, bribery and other illegal activities on its website.
In its most recent earnings report, Alibaba saw an increase of 49% in gross merchandise volume (GMV) reaching $127 billion; 42% of which constituted mobile devices. The company also saw a rise in mobile monthly active users, almost doubling to 265 million.
Alibaba has been rated 16 times by top performing analysts over the past 3 months with 15 bullish ratings and 1 neutral rating, making the top analyst consensus for the e-commerce company a Strong Sell .
Campbell Soup was recently rated a Sell by 4-Star analyst David Driscoll of Citigroup, reasoning that he has grown cautious of the food industry and does not expect sales volumes to improve any time soon.
Campbell’s Soup is currently valued at $14.95 billion.
(NASDAQ: CBOE Volatility Index):
CBOE Holdings is the holding company for Chicago Board Options Exchange (CBOE), CBOE Futures Exchange (CFE) and other subsidiaries. CBOE Holding actually just reported decent fourth quarter earnings results on February 6th but were just shy of analysts’ estimates.
However, many believe the company’s 2015 guidance will be hard to reach due to a drawn-out low unpredictable market, with little traction in VIX futures, and more significant competition.
CBOE Holdings has been rated by 4 top performing analysts over the last 3 months with 2 bearish ratings and 2 neutral ratings, making the company’s top analyst consensus a
Verisign was recently rated a Sell on January 26th by 4-Star analyst Phillip Winslow of Credit Suisse, noting “We believe the risk/reward from VeriSign's current share price, which equates to a NTM EV/UFCF multiple of 13.1 (versus our forecasted 5-year CAGRs for operating profit and EPS of 5.0% and 8.9%, respectively), is biased to the downside given (1) near-term risk to domain name growth and (2) our expectation for slowing operating profit and EPS growth relative to valuation.”
Verisign is currently valued at $7.31 billion.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.